Is the effectiveness of USG-assisted percutaneous release therapy in the treatment of trigger finger disease affected by the stage of the disease?

Abstract

Aim: We aimed to contribute to literature by evaluating the effectiveness of the results of USG-assisted percutaneous release according to the stages of the disease in trigger finger treatment. Material and Method: 81 patients who were examined for trigger finger disease between 2015-2017 were included in the study. USG-assisted percutaneous release was performed on 52 fingers of 52 patients who met the inclusion criteria. According to Quinkel staging, those with grade 1 and 2 were grouped as group 1, and those with grade 3 and 4 were grouped as group 2. After the intervention, our patients were recorded by measuring their visual pain score (VAS) on the 7th day, 1st month and 6th month control and the time to return to work. Results: Thirty-two (61.5%) of the patients were female, 20 (38.5%) were male. In the analysis performed by taking 1st and 2nd grade (group1) and 3rd and 4th grade (group 2) together, it was determined that there was a significant relationship between grade and VAS scores. It was seen that this relationship was effective on all 4 VAS scores. It was determined that the mean of all 4 VAS scores in the second group was statistically significantly higher than the first group (p <0.001). In the comparison of the time to return to work according to grade, it was determined that group 1 could return to work earlier than group 2 (1.67 ± 0.77 and 2.09 ± 0.83, respectively), but this difference was not statistically significant. Conclusion: We think that the percutaneous release procedure, which is performed carefully after the location of the lesion has been precisely determined and marked by USG, is a method that can be preferred especially in the early stages of the disease.